Why Ashwagandha Product Quality Varies Enormously
Ashwagandha (Withania somnifera) is an adaptogenic herb from the Solanaceae family, but not all ashwagandha products are equivalent. The active constituents are the withanolides — a group of steroidal lactones of which withaferin A and withanolide D are the most biologically active. Generic ashwagandha root powder typically contains 0.1-0.5% withanolides. KSM-66 is a standardised extract containing greater than 5% withanolides and is derived from roots only — leaf extracts are excluded because they contain different withanolide profiles and higher concentrations of withaferin A, which can be cytotoxic at high doses. This quality distinction is the difference between a product with robust clinical evidence and a cheap powder with minimal active content.
Cortisol Reduction and Stress Response
The most consistent finding in ashwagandha research is its ability to reduce cortisol levels and improve stress adaptation. A 2019 randomised controlled trial in adults with chronic stress found that 300mg of KSM-66 twice daily reduced Perceived Stress Scale scores by 30% and morning cortisol levels by 23% compared to placebo after 8 weeks. The mechanism involves dampening the hypothalamic-pituitary-adrenal (HPA) axis — reducing the upstream drive to produce cortisol rather than simply blocking cortisol at the receptor level. This is a fundamentally different and more physiological mechanism than pharmaceutical cortisol blockers, which carry significant side effect risks.
Anxiety Relief Without Sedation
Unlike benzodiazepines and other pharmaceutical anxiolytics, KSM-66 ashwagandha does not impair cognitive performance or cause sedation at therapeutic doses. A 2013 study in people with generalised anxiety disorder found that KSM-66 at 300mg twice daily reduced Hamilton Anxiety Rating Scale scores as effectively as the benzodiazepine lorazepam, but without the cognitive impairment and risk of dependence. The anxiolytic mechanism involves GABAergic modulation (similar to how benzodiazepines work) as well as cortisol reduction — providing two complementary anxiety-reducing pathways. This makes it uniquely useful for people who need anxiety relief without functional impairment.
Synergy with CitrusBurn
The combination of ashwagandha and CitrusBurn addresses stress-related weight gain from two complementary angles. Chronic cortisol elevation drives visceral fat accumulation — cortisol activates lipoprotein lipase in abdominal adipocytes, promoting fat storage in the omental (belly) fat depot. By reducing cortisol, ashwagandha addresses the hormonal driver of stubborn belly fat accumulation. CitrusBurn simultaneously increases metabolic rate through thermogenesis, creating a calorie deficit. Together, they address both the endocrine driver of fat storage and the metabolic rate — making them more effective in combination than either compound alone.
Choosing the Right Product
Look for KSM-66 specifically — it is the most clinically researched ashwagandha form and is certified to contain greater than 5% withanolides with a certificate of analysis. The typical therapeutic dose is 300-600mg daily of KSM-66. Avoid leaf extracts and generic ashwagandha powders unless accompanied by a third-party withanolide content test. Ashwagandha is generally well tolerated, though it should not be combined with thyroid medications without medical supervision because it can stimulate thyroid function. Pregnant women should avoid ashwagandha due to potential uterine effects.
KSM-66 vs Other Extracts: Why the Form Matters
Not all ashwagandha extracts are created equal. The KSM-66 extract, standardised to greater than 5% withanolides and derived from roots only, has the largest and most rigorous trial database, demonstrating meaningful reductions in perceived stress scores within 8-12 weeks in multiple randomised controlled trials. Many commercial products use whole-root powders or low-potency leaf extracts containing minimal withanolides. Evidence-based supplementation requires a standardised extract at 300-600mg per day of KSM-66 or equivalent.
Mechanism: How Withanolides Calm the Nervous System
The active constituents bind GABA-A receptors, producing anxiolytic effects without sedation, inhibit cortisol synthesis in adrenal cortex cells, and reduce neuroinflammation via NF-kB and TNF-alpha suppression. Unlike pharmaceutical anxiolytics, standard doses do not impair cognitive performance or create physical dependence. The cortisol-lowering effect is particularly relevant for people whose stress manifests as metabolic dysfunction.
KSM-66 vs Other Extracts: Why the Form Matters
Not all ashwagandha extracts are created equal. The KSM-66 extract, standardised to greater than 5% withanolides and derived from roots only, has the largest and most rigorous trial database, demonstrating meaningful reductions in perceived stress scores within 8-12 weeks in multiple randomised controlled trials. Many commercial products use whole-root powders or low-potency leaf extracts containing minimal withanolides. Evidence-based supplementation requires a standardised extract at 300-600mg per day of KSM-66 or equivalent.
Mechanism: How Withanolides Calm the Nervous System
The active constituents bind GABA-A receptors, producing anxiolytic effects without sedation, inhibit cortisol synthesis in adrenal cortex cells, and reduce neuroinflammation via NF-kB and TNF-alpha suppression. Unlike pharmaceutical anxiolytics, standard doses do not impair cognitive performance or create physical dependence. The cortisol-lowering effect is particularly relevant for people whose stress manifests as metabolic dysfunction.
Leave a Reply